| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Exposure Delayed Effects | 94 | 2023 | 2408 | 10.020 |
Why?
|
| Adiposity | 62 | 2023 | 1807 | 8.330 |
Why?
|
| Fluorocarbons | 33 | 2023 | 452 | 7.370 |
Why?
|
| Environmental Pollutants | 48 | 2024 | 1179 | 7.310 |
Why?
|
| Weight Gain | 51 | 2021 | 2292 | 5.390 |
Why?
|
| Pregnancy | 296 | 2024 | 29144 | 5.340 |
Why?
|
| Alkanesulfonic Acids | 23 | 2023 | 180 | 5.310 |
Why?
|
| Breast Feeding | 37 | 2023 | 1338 | 4.740 |
Why?
|
| Child Development | 43 | 2023 | 2223 | 4.550 |
Why?
|
| Fetal Blood | 41 | 2023 | 1318 | 4.430 |
Why?
|
| Seafood | 18 | 2024 | 384 | 4.310 |
Why?
|
| Body Mass Index | 119 | 2023 | 12720 | 4.180 |
Why?
|
| Birth Weight | 51 | 2024 | 2069 | 4.080 |
Why?
|
| Diet | 54 | 2024 | 7939 | 3.820 |
Why?
|
| Diabetes, Gestational | 27 | 2023 | 1184 | 3.710 |
Why?
|
| Fetal Development | 21 | 2022 | 767 | 3.510 |
Why?
|
| Maternal Exposure | 31 | 2024 | 961 | 3.460 |
Why?
|
| Obesity | 82 | 2024 | 12745 | 3.230 |
Why?
|
| Fishes | 14 | 2024 | 569 | 3.220 |
Why?
|
| Mothers | 38 | 2023 | 2165 | 3.150 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 13 | 2022 | 378 | 2.710 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 10 | 2021 | 159 | 2.710 |
Why?
|
| Postpartum Period | 23 | 2023 | 1086 | 2.640 |
Why?
|
| Child | 239 | 2024 | 77709 | 2.550 |
Why?
|
| Cognition | 33 | 2023 | 6770 | 2.420 |
Why?
|
| Blood Pressure | 36 | 2023 | 8554 | 2.420 |
Why?
|
| Mercury | 11 | 2023 | 285 | 2.380 |
Why?
|
| DNA Methylation | 38 | 2024 | 4286 | 2.370 |
Why?
|
| Pregnancy Trimester, Second | 26 | 2022 | 732 | 2.360 |
Why?
|
| Pregnancy Complications | 36 | 2022 | 2861 | 2.360 |
Why?
|
| Hypertension, Pregnancy-Induced | 14 | 2024 | 489 | 2.320 |
Why?
|
| Pregnancy Trimesters | 11 | 2020 | 192 | 2.310 |
Why?
|
| Glucose Intolerance | 11 | 2020 | 577 | 2.300 |
Why?
|
| Infant, Newborn | 139 | 2024 | 25625 | 2.270 |
Why?
|
| Premature Birth | 18 | 2024 | 1721 | 2.240 |
Why?
|
| Gestational Age | 34 | 2023 | 3493 | 2.210 |
Why?
|
| Body Weight | 24 | 2022 | 4669 | 2.200 |
Why?
|
| Caprylates | 11 | 2021 | 111 | 2.190 |
Why?
|
| Child, Preschool | 151 | 2024 | 41006 | 2.170 |
Why?
|
| Female | 433 | 2024 | 380194 | 2.160 |
Why?
|
| Environmental Exposure | 32 | 2024 | 4234 | 2.040 |
Why?
|
| Fatty Acids, Omega-3 | 12 | 2024 | 1344 | 2.010 |
Why?
|
| Prediabetic State | 4 | 2021 | 499 | 1.970 |
Why?
|
| Overweight | 29 | 2023 | 2371 | 1.960 |
Why?
|
| Asthma | 34 | 2023 | 6011 | 1.850 |
Why?
|
| Food Contamination | 7 | 2021 | 188 | 1.820 |
Why?
|
| Hair | 7 | 2023 | 483 | 1.790 |
Why?
|
| Infant | 108 | 2023 | 35136 | 1.760 |
Why?
|
| Prospective Studies | 132 | 2024 | 53288 | 1.730 |
Why?
|
| Child Behavior | 9 | 2023 | 839 | 1.730 |
Why?
|
| Pregnancy Trimester, First | 16 | 2022 | 853 | 1.710 |
Why?
|
| Massachusetts | 53 | 2022 | 8663 | 1.690 |
Why?
|
| Feeding Behavior | 19 | 2024 | 3188 | 1.670 |
Why?
|
| Methylmercury Compounds | 7 | 2021 | 96 | 1.650 |
Why?
|
| Dietary Proteins | 6 | 2019 | 963 | 1.640 |
Why?
|
| Leptin | 13 | 2021 | 1599 | 1.630 |
Why?
|
| Humans | 486 | 2024 | 744343 | 1.620 |
Why?
|
| Metabolic Diseases | 7 | 2021 | 658 | 1.590 |
Why?
|
| Infertility | 5 | 2024 | 655 | 1.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2024 | 11725 | 1.530 |
Why?
|
| Thyroxine | 9 | 2024 | 667 | 1.510 |
Why?
|
| Anthropometry | 15 | 2022 | 1350 | 1.500 |
Why?
|
| Phthalic Acids | 10 | 2024 | 436 | 1.500 |
Why?
|
| Cohort Studies | 111 | 2024 | 40561 | 1.490 |
Why?
|
| Insulin-Like Growth Factor I | 6 | 2019 | 2015 | 1.480 |
Why?
|
| Blood Glucose | 19 | 2022 | 6256 | 1.450 |
Why?
|
| Air Pollution | 16 | 2023 | 2286 | 1.440 |
Why?
|
| Body Composition | 14 | 2023 | 2401 | 1.440 |
Why?
|
| Adult | 198 | 2024 | 214055 | 1.380 |
Why?
|
| Insulin-Like Growth Factor II | 4 | 2021 | 271 | 1.380 |
Why?
|
| Prenatal Care | 12 | 2019 | 1092 | 1.370 |
Why?
|
| Pregnancy Outcome | 24 | 2022 | 2795 | 1.350 |
Why?
|
| Fetal Growth Retardation | 5 | 2016 | 570 | 1.340 |
Why?
|
| Adolescent | 124 | 2024 | 85781 | 1.290 |
Why?
|
| Cardiovascular Diseases | 25 | 2022 | 15165 | 1.270 |
Why?
|
| Waist Circumference | 15 | 2022 | 917 | 1.270 |
Why?
|
| Endocrine Disruptors | 4 | 2022 | 237 | 1.260 |
Why?
|
| Male | 241 | 2024 | 350118 | 1.260 |
Why?
|
| Republic of Belarus | 15 | 2021 | 38 | 1.230 |
Why?
|
| Sexual Maturation | 2 | 2019 | 265 | 1.220 |
Why?
|
| Body Height | 13 | 2024 | 1577 | 1.190 |
Why?
|
| Executive Function | 11 | 2022 | 1364 | 1.180 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2017 | 424 | 1.160 |
Why?
|
| Air Pollutants | 14 | 2022 | 2817 | 1.150 |
Why?
|
| Depression, Postpartum | 4 | 2023 | 340 | 1.140 |
Why?
|
| Growth | 3 | 2017 | 376 | 1.130 |
Why?
|
| Adiponectin | 12 | 2022 | 1100 | 1.110 |
Why?
|
| Thyroid Function Tests | 6 | 2022 | 286 | 1.090 |
Why?
|
| Dermatitis, Atopic | 6 | 2019 | 654 | 1.060 |
Why?
|
| Dietary Sucrose | 2 | 2018 | 246 | 1.060 |
Why?
|
| Acetaminophen | 2 | 2020 | 545 | 1.060 |
Why?
|
| Risk Factors | 86 | 2024 | 72290 | 1.060 |
Why?
|
| Longitudinal Studies | 44 | 2024 | 13989 | 1.040 |
Why?
|
| Health Promotion | 16 | 2023 | 2205 | 1.040 |
Why?
|
| Insulin Resistance | 13 | 2021 | 3864 | 1.020 |
Why?
|
| Shellfish | 2 | 2015 | 38 | 1.000 |
Why?
|
| Metabolomics | 6 | 2020 | 1484 | 1.000 |
Why?
|
| Pre-Eclampsia | 7 | 2024 | 1200 | 0.990 |
Why?
|
| Docosahexaenoic Acids | 7 | 2023 | 875 | 0.990 |
Why?
|
| Infant Formula | 8 | 2022 | 199 | 0.990 |
Why?
|
| Maternal Welfare | 4 | 2014 | 115 | 0.980 |
Why?
|
| Food | 4 | 2023 | 771 | 0.970 |
Why?
|
| Lead | 8 | 2023 | 852 | 0.970 |
Why?
|
| Dietary Supplements | 8 | 2024 | 3297 | 0.940 |
Why?
|
| Linear Models | 27 | 2023 | 5952 | 0.940 |
Why?
|
| Infant Nutritional Physiological Phenomena | 11 | 2023 | 347 | 0.920 |
Why?
|
| Socioeconomic Factors | 26 | 2023 | 7785 | 0.910 |
Why?
|
| Metals | 4 | 2023 | 719 | 0.910 |
Why?
|
| Hydrocortisone | 5 | 2023 | 1826 | 0.900 |
Why?
|
| Beverages | 4 | 2022 | 820 | 0.890 |
Why?
|
| Birth Order | 1 | 2023 | 95 | 0.880 |
Why?
|
| Hormones | 2 | 2017 | 889 | 0.870 |
Why?
|
| Cesarean Section | 7 | 2021 | 1365 | 0.840 |
Why?
|
| Maternal Behavior | 3 | 2019 | 311 | 0.840 |
Why?
|
| Vitamin D | 4 | 2021 | 3223 | 0.830 |
Why?
|
| Pregnancy Trimester, Third | 6 | 2022 | 571 | 0.800 |
Why?
|
| Puberty | 4 | 2024 | 490 | 0.800 |
Why?
|
| Intelligence | 7 | 2022 | 920 | 0.790 |
Why?
|
| Pregnant Women | 4 | 2020 | 568 | 0.790 |
Why?
|
| Particulate Matter | 13 | 2021 | 2530 | 0.790 |
Why?
|
| Smoking | 16 | 2020 | 8987 | 0.780 |
Why?
|
| Body Weights and Measures | 4 | 2020 | 211 | 0.780 |
Why?
|
| Arsenic | 5 | 2024 | 328 | 0.780 |
Why?
|
| Nasal Mucosa | 2 | 2021 | 373 | 0.770 |
Why?
|
| Diet Surveys | 6 | 2022 | 1173 | 0.760 |
Why?
|
| Multivariate Analysis | 28 | 2021 | 12245 | 0.760 |
Why?
|
| Sweetening Agents | 3 | 2022 | 296 | 0.740 |
Why?
|
| Menarche | 2 | 2021 | 516 | 0.740 |
Why?
|
| Metabolism | 2 | 2018 | 196 | 0.720 |
Why?
|
| Life Style | 12 | 2021 | 3835 | 0.720 |
Why?
|
| Lipids | 10 | 2024 | 3305 | 0.720 |
Why?
|
| Hepatitis B, Chronic | 3 | 2019 | 393 | 0.710 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2024 | 370 | 0.700 |
Why?
|
| Epigenesis, Genetic | 23 | 2024 | 3647 | 0.700 |
Why?
|
| Inflammation | 13 | 2023 | 10638 | 0.700 |
Why?
|
| Follow-Up Studies | 38 | 2021 | 39050 | 0.690 |
Why?
|
| Absorptiometry, Photon | 10 | 2021 | 1725 | 0.690 |
Why?
|
| Hand Strength | 1 | 2022 | 448 | 0.680 |
Why?
|
| United States | 60 | 2024 | 69872 | 0.680 |
Why?
|
| Micronutrients | 6 | 2023 | 375 | 0.680 |
Why?
|
| Maternal Age | 9 | 2019 | 802 | 0.680 |
Why?
|
| Postnatal Care | 3 | 2016 | 236 | 0.680 |
Why?
|
| Boston | 22 | 2021 | 9313 | 0.670 |
Why?
|
| Menopause | 4 | 2023 | 1626 | 0.670 |
Why?
|
| Mexico | 15 | 2022 | 690 | 0.670 |
Why?
|
| Vehicle Emissions | 5 | 2022 | 665 | 0.670 |
Why?
|
| Adolescent Development | 2 | 2019 | 278 | 0.670 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2011 | 227 | 0.670 |
Why?
|
| Crown-Rump Length | 1 | 2018 | 32 | 0.660 |
Why?
|
| Satiation | 1 | 2019 | 80 | 0.660 |
Why?
|
| Food Hypersensitivity | 6 | 2022 | 622 | 0.660 |
Why?
|
| Appetite Regulation | 1 | 2019 | 88 | 0.650 |
Why?
|
| Respiratory Sounds | 8 | 2021 | 696 | 0.640 |
Why?
|
| Parturition | 6 | 2023 | 441 | 0.640 |
Why?
|
| Selenium | 2 | 2022 | 405 | 0.630 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2020 | 546 | 0.630 |
Why?
|
| Health Status | 5 | 2024 | 4034 | 0.630 |
Why?
|
| Ibuprofen | 1 | 2019 | 236 | 0.620 |
Why?
|
| Heart | 2 | 2024 | 4467 | 0.620 |
Why?
|
| Anxiety | 5 | 2023 | 4297 | 0.620 |
Why?
|
| Food Preferences | 3 | 2020 | 399 | 0.620 |
Why?
|
| Child Abuse | 2 | 2023 | 1030 | 0.620 |
Why?
|
| Milk, Human | 5 | 2019 | 490 | 0.600 |
Why?
|
| Thyroid Diseases | 4 | 2022 | 379 | 0.600 |
Why?
|
| Insulin | 6 | 2021 | 6580 | 0.590 |
Why?
|
| Sarcopenia | 1 | 2022 | 368 | 0.590 |
Why?
|
| Television | 5 | 2018 | 409 | 0.590 |
Why?
|
| Adipokines | 3 | 2020 | 319 | 0.590 |
Why?
|
| Young Adult | 48 | 2023 | 56430 | 0.580 |
Why?
|
| Glucose Tolerance Test | 9 | 2020 | 1150 | 0.580 |
Why?
|
| Sleep | 10 | 2023 | 4623 | 0.570 |
Why?
|
| Homeless Youth | 1 | 2017 | 45 | 0.570 |
Why?
|
| Lead Poisoning | 2 | 2019 | 301 | 0.570 |
Why?
|
| Skinfold Thickness | 8 | 2017 | 162 | 0.560 |
Why?
|
| Religion | 1 | 2019 | 356 | 0.560 |
Why?
|
| Dyslipidemias | 1 | 2024 | 849 | 0.560 |
Why?
|
| Parity | 8 | 2023 | 929 | 0.550 |
Why?
|
| Psychomotor Disorders | 1 | 2017 | 152 | 0.550 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 550 | 0.540 |
Why?
|
| Health Behavior | 8 | 2022 | 2636 | 0.540 |
Why?
|
| Depression | 11 | 2023 | 7766 | 0.530 |
Why?
|
| Cross-Sectional Studies | 29 | 2023 | 25043 | 0.530 |
Why?
|
| Diabetes Mellitus | 4 | 2019 | 5751 | 0.530 |
Why?
|
| Choline | 3 | 2022 | 493 | 0.530 |
Why?
|
| Peptide Hormones | 1 | 2016 | 134 | 0.530 |
Why?
|
| Infant, Small for Gestational Age | 6 | 2017 | 440 | 0.530 |
Why?
|
| Exercise | 13 | 2022 | 5615 | 0.520 |
Why?
|
| Child Nutritional Physiological Phenomena | 4 | 2018 | 303 | 0.510 |
Why?
|
| Diet, Mediterranean | 3 | 2022 | 700 | 0.500 |
Why?
|
| Iodide Peroxidase | 5 | 2022 | 293 | 0.490 |
Why?
|
| Child Behavior Disorders | 1 | 2019 | 807 | 0.490 |
Why?
|
| Risk Assessment | 20 | 2020 | 23338 | 0.490 |
Why?
|
| Hypersensitivity, Immediate | 4 | 2019 | 337 | 0.490 |
Why?
|
| Logistic Models | 26 | 2021 | 13408 | 0.490 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2017 | 370 | 0.490 |
Why?
|
| Weight Loss | 5 | 2020 | 2622 | 0.490 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2021 | 2026 | 0.490 |
Why?
|
| Maternal-Fetal Exchange | 7 | 2020 | 456 | 0.470 |
Why?
|
| Thyrotropin | 8 | 2024 | 849 | 0.470 |
Why?
|
| Erythrocytes | 3 | 2021 | 2455 | 0.470 |
Why?
|
| Choice Behavior | 1 | 2019 | 803 | 0.470 |
Why?
|
| Community Health Planning | 1 | 2014 | 165 | 0.450 |
Why?
|
| Bayes Theorem | 16 | 2023 | 2309 | 0.450 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 1320 | 0.450 |
Why?
|
| Advisory Committees | 1 | 2017 | 775 | 0.440 |
Why?
|
| Eating | 4 | 2021 | 1536 | 0.430 |
Why?
|
| Aquaculture | 1 | 2012 | 25 | 0.420 |
Why?
|
| Preventive Health Services | 1 | 2017 | 575 | 0.420 |
Why?
|
| C-Reactive Protein | 10 | 2023 | 3778 | 0.420 |
Why?
|
| Dietary Fats | 4 | 2021 | 2017 | 0.420 |
Why?
|
| Women's Health | 2 | 2011 | 2034 | 0.410 |
Why?
|
| Counseling | 3 | 2017 | 1523 | 0.410 |
Why?
|
| Prevalence | 18 | 2023 | 15226 | 0.400 |
Why?
|
| Thyroid Gland | 5 | 2022 | 1173 | 0.400 |
Why?
|
| Parents | 3 | 2020 | 3407 | 0.400 |
Why?
|
| Residence Characteristics | 8 | 2023 | 2050 | 0.400 |
Why?
|
| Odds Ratio | 17 | 2022 | 9849 | 0.400 |
Why?
|
| Lutein | 2 | 2022 | 125 | 0.400 |
Why?
|
| Infant, Premature | 5 | 2020 | 2044 | 0.400 |
Why?
|
| Toxicology | 1 | 2012 | 106 | 0.400 |
Why?
|
| Alanine Transaminase | 3 | 2018 | 592 | 0.390 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 1456 | 0.380 |
Why?
|
| Folic Acid | 8 | 2023 | 1300 | 0.380 |
Why?
|
| Cluster Analysis | 8 | 2018 | 2715 | 0.380 |
Why?
|
| Decanoic Acids | 3 | 2021 | 67 | 0.380 |
Why?
|
| Nutrition Disorders | 1 | 2011 | 211 | 0.380 |
Why?
|
| Patient Compliance | 3 | 2017 | 2684 | 0.380 |
Why?
|
| Goals | 2 | 2016 | 706 | 0.370 |
Why?
|
| Androgens | 1 | 2018 | 1281 | 0.370 |
Why?
|
| Fatty Acids | 3 | 2016 | 1809 | 0.370 |
Why?
|
| Genome-Wide Association Study | 13 | 2024 | 12261 | 0.360 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 832 | 0.360 |
Why?
|
| Phenols | 2 | 2024 | 497 | 0.360 |
Why?
|
| Social Support | 1 | 2019 | 2118 | 0.350 |
Why?
|
| Thinness | 5 | 2020 | 480 | 0.350 |
Why?
|
| Infant Welfare | 1 | 2009 | 81 | 0.340 |
Why?
|
| Guideline Adherence | 3 | 2017 | 2266 | 0.340 |
Why?
|
| Community Health Services | 1 | 2014 | 650 | 0.330 |
Why?
|
| Stress, Psychological | 4 | 2023 | 4245 | 0.330 |
Why?
|
| Age Factors | 14 | 2023 | 18370 | 0.330 |
Why?
|
| Health Maintenance Organizations | 3 | 2006 | 642 | 0.330 |
Why?
|
| Delivery, Obstetric | 4 | 2021 | 906 | 0.330 |
Why?
|
| Mercury Poisoning, Nervous System | 1 | 2008 | 8 | 0.320 |
Why?
|
| Time Factors | 25 | 2020 | 40075 | 0.320 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3086 | 0.320 |
Why?
|
| Hyperglycemia | 4 | 2022 | 1373 | 0.310 |
Why?
|
| CpG Islands | 10 | 2022 | 1172 | 0.310 |
Why?
|
| Obstetrics | 3 | 2015 | 658 | 0.310 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2018 | 3923 | 0.310 |
Why?
|
| Hemodynamics | 1 | 2018 | 4199 | 0.300 |
Why?
|
| Benzhydryl Compounds | 2 | 2024 | 845 | 0.300 |
Why?
|
| Hypothyroidism | 3 | 2022 | 658 | 0.300 |
Why?
|
| Hypertension | 6 | 2020 | 8480 | 0.300 |
Why?
|
| Documentation | 1 | 2013 | 871 | 0.300 |
Why?
|
| Nutrition Surveys | 5 | 2021 | 1660 | 0.290 |
Why?
|
| Pregnancy in Adolescence | 1 | 2008 | 158 | 0.290 |
Why?
|
| Incidence | 14 | 2023 | 20947 | 0.280 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2018 | 369 | 0.280 |
Why?
|
| Lactation | 4 | 2023 | 412 | 0.280 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2020 | 365 | 0.280 |
Why?
|
| Educational Status | 10 | 2023 | 2540 | 0.280 |
Why?
|
| Causality | 4 | 2021 | 1275 | 0.260 |
Why?
|
| Environment Design | 2 | 2021 | 178 | 0.260 |
Why?
|
| Preconception Care | 1 | 2006 | 134 | 0.260 |
Why?
|
| Triglycerides | 5 | 2019 | 2454 | 0.260 |
Why?
|
| Self Report | 5 | 2022 | 3558 | 0.260 |
Why?
|
| Infant Food | 3 | 2014 | 141 | 0.260 |
Why?
|
| Sex Factors | 9 | 2022 | 10397 | 0.260 |
Why?
|
| Regression Analysis | 8 | 2020 | 6459 | 0.250 |
Why?
|
| Eggs | 2 | 2022 | 184 | 0.250 |
Why?
|
| Allergens | 5 | 2022 | 1320 | 0.250 |
Why?
|
| Infant, Low Birth Weight | 4 | 2020 | 850 | 0.250 |
Why?
|
| Autoantibodies | 5 | 2022 | 2035 | 0.240 |
Why?
|
| Hyperthyroidism | 3 | 2022 | 295 | 0.240 |
Why?
|
| Pediatrics | 2 | 2017 | 3475 | 0.240 |
Why?
|
| Epigenomics | 5 | 2023 | 903 | 0.240 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 438 | 0.230 |
Why?
|
| Hypersensitivity | 3 | 2023 | 1102 | 0.230 |
Why?
|
| Attitude | 3 | 2019 | 776 | 0.220 |
Why?
|
| Emotions | 4 | 2023 | 2661 | 0.220 |
Why?
|
| Spirometry | 2 | 2018 | 864 | 0.220 |
Why?
|
| Eicosapentaenoic Acid | 3 | 2023 | 582 | 0.220 |
Why?
|
| Diet Fads | 1 | 2002 | 13 | 0.220 |
Why?
|
| Seasons | 4 | 2023 | 1493 | 0.220 |
Why?
|
| Risk | 4 | 2024 | 9687 | 0.220 |
Why?
|
| Iodine | 3 | 2008 | 286 | 0.220 |
Why?
|
| Immunoglobulin E | 5 | 2022 | 1463 | 0.220 |
Why?
|
| Autistic Disorder | 2 | 2022 | 1185 | 0.210 |
Why?
|
| Egg Hypersensitivity | 1 | 2022 | 44 | 0.210 |
Why?
|
| Milk | 3 | 2022 | 450 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 7279 | 0.210 |
Why?
|
| Betaine | 2 | 2013 | 87 | 0.210 |
Why?
|
| Interviews as Topic | 5 | 2013 | 2539 | 0.210 |
Why?
|
| Animals | 24 | 2024 | 168757 | 0.210 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2021 | 6038 | 0.210 |
Why?
|
| Social Behavior | 2 | 2021 | 1127 | 0.210 |
Why?
|
| Population Surveillance | 2 | 2021 | 2616 | 0.200 |
Why?
|
| Walking | 3 | 2012 | 1180 | 0.200 |
Why?
|
| Menstrual Cycle | 2 | 2022 | 551 | 0.200 |
Why?
|
| Cholesterol | 4 | 2019 | 2917 | 0.200 |
Why?
|
| Environmental Monitoring | 4 | 2017 | 1414 | 0.200 |
Why?
|
| Zinc | 2 | 2024 | 684 | 0.200 |
Why?
|
| Environment | 3 | 2021 | 1124 | 0.200 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 76 | 0.200 |
Why?
|
| Quality of Health Care | 1 | 2017 | 4371 | 0.200 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2021 | 141 | 0.200 |
Why?
|
| Menopause, Premature | 1 | 2022 | 132 | 0.190 |
Why?
|
| Manganese | 2 | 2021 | 408 | 0.190 |
Why?
|
| Energy Intake | 5 | 2021 | 2148 | 0.190 |
Why?
|
| Interleukin-13 | 2 | 2017 | 389 | 0.190 |
Why?
|
| Child Care | 2 | 2023 | 119 | 0.190 |
Why?
|
| Obesity, Abdominal | 2 | 2021 | 361 | 0.190 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 780 | 0.190 |
Why?
|
| Mental Health | 2 | 2014 | 3019 | 0.190 |
Why?
|
| Interleukin-6 | 3 | 2014 | 3200 | 0.190 |
Why?
|
| gamma-Tocopherol | 1 | 2020 | 31 | 0.190 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2023 | 402 | 0.190 |
Why?
|
| Surface Plasmon Resonance | 1 | 2021 | 274 | 0.180 |
Why?
|
| Metals, Heavy | 1 | 2021 | 139 | 0.180 |
Why?
|
| Nickel | 1 | 2020 | 130 | 0.180 |
Why?
|
| Clinical Competence | 3 | 2018 | 4687 | 0.180 |
Why?
|
| Child Welfare | 1 | 2004 | 523 | 0.180 |
Why?
|
| Mass Screening | 2 | 2016 | 5255 | 0.180 |
Why?
|
| Actigraphy | 3 | 2019 | 488 | 0.180 |
Why?
|
| Christianity | 1 | 2019 | 47 | 0.180 |
Why?
|
| Sulfonic Acids | 2 | 2021 | 96 | 0.180 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2020 | 93 | 0.180 |
Why?
|
| Scotland | 1 | 2019 | 155 | 0.180 |
Why?
|
| Overnutrition | 1 | 2019 | 26 | 0.180 |
Why?
|
| Radioactivity | 1 | 2020 | 63 | 0.180 |
Why?
|
| Behavior | 2 | 2021 | 561 | 0.180 |
Why?
|
| Middle Aged | 16 | 2024 | 213383 | 0.180 |
Why?
|
| alpha-Tocopherol | 1 | 2020 | 127 | 0.180 |
Why?
|
| Body Size | 2 | 2022 | 461 | 0.170 |
Why?
|
| Genomic Imprinting | 1 | 2021 | 328 | 0.170 |
Why?
|
| Abdominal Fat | 1 | 2021 | 223 | 0.170 |
Why?
|
| Vegetables | 3 | 2021 | 1182 | 0.170 |
Why?
|
| Vitamin B 12 | 2 | 2013 | 527 | 0.170 |
Why?
|
| Fructosamine | 1 | 2018 | 14 | 0.170 |
Why?
|
| Greece | 2 | 2017 | 344 | 0.170 |
Why?
|
| Environmental Illness | 1 | 2019 | 34 | 0.170 |
Why?
|
| Paternal Exposure | 1 | 2019 | 89 | 0.170 |
Why?
|
| Soot | 2 | 2018 | 232 | 0.170 |
Why?
|
| Japan | 2 | 2020 | 1360 | 0.170 |
Why?
|
| Nonprescription Drugs | 1 | 2020 | 116 | 0.170 |
Why?
|
| Nutritional Status | 6 | 2021 | 1609 | 0.160 |
Why?
|
| Proteobacteria | 1 | 2018 | 45 | 0.160 |
Why?
|
| Diet, Reducing | 1 | 2002 | 462 | 0.160 |
Why?
|
| Language Development | 2 | 2010 | 187 | 0.160 |
Why?
|
| Reproducibility of Results | 10 | 2023 | 19905 | 0.160 |
Why?
|
| Vitamin D Deficiency | 2 | 2021 | 1343 | 0.160 |
Why?
|
| Bone Density | 3 | 2023 | 3468 | 0.160 |
Why?
|
| DNA-Binding Proteins | 4 | 2021 | 9648 | 0.160 |
Why?
|
| Puberty, Precocious | 1 | 2019 | 156 | 0.160 |
Why?
|
| Likelihood Functions | 1 | 2021 | 1005 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2020 | 9959 | 0.150 |
Why?
|
| Tetanus Toxoid | 1 | 1998 | 193 | 0.150 |
Why?
|
| Europe | 6 | 2020 | 3339 | 0.150 |
Why?
|
| Confidence Intervals | 5 | 2017 | 2971 | 0.150 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2017 | 100 | 0.150 |
Why?
|
| Nutrition Assessment | 3 | 2018 | 723 | 0.150 |
Why?
|
| Pesticide Residues | 1 | 2018 | 95 | 0.150 |
Why?
|
| Denmark | 4 | 2017 | 738 | 0.150 |
Why?
|
| Peripartum Period | 1 | 2018 | 133 | 0.150 |
Why?
|
| Reference Values | 3 | 2022 | 4982 | 0.150 |
Why?
|
| Hypotension | 1 | 2023 | 884 | 0.150 |
Why?
|
| Glucocorticoids | 2 | 2023 | 2107 | 0.150 |
Why?
|
| Depressive Disorder | 1 | 2010 | 3748 | 0.150 |
Why?
|
| Pilot Projects | 4 | 2018 | 8324 | 0.150 |
Why?
|
| Nitric Oxide | 3 | 2023 | 2132 | 0.150 |
Why?
|
| Wood | 1 | 2017 | 89 | 0.150 |
Why?
|
| Adipose Tissue | 6 | 2019 | 3279 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2022 | 1695 | 0.150 |
Why?
|
| Anemia | 1 | 2006 | 1506 | 0.140 |
Why?
|
| World Health Organization | 2 | 2013 | 1318 | 0.140 |
Why?
|
| Vitamin E | 2 | 2018 | 869 | 0.140 |
Why?
|
| Psychomotor Performance | 3 | 2010 | 1901 | 0.140 |
Why?
|
| Carbon | 2 | 2024 | 687 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2013 | 4468 | 0.140 |
Why?
|
| Heating | 1 | 2017 | 97 | 0.140 |
Why?
|
| Public Health | 4 | 2023 | 2603 | 0.140 |
Why?
|
| Fruit | 2 | 2019 | 1142 | 0.140 |
Why?
|
| Glycemic Index | 1 | 2018 | 395 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 977 | 0.140 |
Why?
|
| Water Pollutants, Chemical | 2 | 2011 | 311 | 0.140 |
Why?
|
| Vision, Low | 1 | 2018 | 168 | 0.140 |
Why?
|
| Models, Statistical | 4 | 2016 | 5102 | 0.140 |
Why?
|
| Snoring | 1 | 2017 | 191 | 0.140 |
Why?
|
| Arteries | 1 | 2021 | 1119 | 0.130 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2017 | 311 | 0.130 |
Why?
|
| Waist-Hip Ratio | 2 | 2014 | 517 | 0.130 |
Why?
|
| Nutritional Requirements | 3 | 2002 | 286 | 0.130 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 63 | 0.130 |
Why?
|
| North America | 4 | 2020 | 1249 | 0.130 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 1743 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2010 | 4043 | 0.130 |
Why?
|
| Smoke | 1 | 2017 | 227 | 0.130 |
Why?
|
| Databases, Factual | 6 | 2019 | 7729 | 0.130 |
Why?
|
| Brazil | 1 | 2020 | 1270 | 0.130 |
Why?
|
| Adrenal Glands | 1 | 1998 | 546 | 0.130 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2018 | 168 | 0.130 |
Why?
|
| Thyrotoxicosis | 1 | 1995 | 82 | 0.130 |
Why?
|
| Indians, North American | 2 | 1997 | 355 | 0.130 |
Why?
|
| Diet Records | 1 | 2017 | 425 | 0.130 |
Why?
|
| Pituitary Gland | 1 | 1998 | 665 | 0.130 |
Why?
|
| Intra-Abdominal Fat | 1 | 2020 | 591 | 0.130 |
Why?
|
| Nutrition Policy | 2 | 2010 | 488 | 0.130 |
Why?
|
| Vital Capacity | 1 | 2018 | 925 | 0.130 |
Why?
|
| Iron | 2 | 2008 | 1774 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 3 | 2013 | 2212 | 0.130 |
Why?
|
| Age of Onset | 1 | 2022 | 3271 | 0.130 |
Why?
|
| Microvessels | 1 | 2019 | 544 | 0.130 |
Why?
|
| Pandemics | 3 | 2023 | 8388 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 563 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2018 | 676 | 0.130 |
Why?
|
| C-Peptide | 1 | 2016 | 419 | 0.120 |
Why?
|
| Siblings | 1 | 2019 | 854 | 0.120 |
Why?
|
| Guidelines as Topic | 3 | 2017 | 1405 | 0.120 |
Why?
|
| Parenting | 1 | 2020 | 679 | 0.120 |
Why?
|
| Health Services Misuse | 1 | 2016 | 243 | 0.120 |
Why?
|
| Inhalation Exposure | 1 | 2017 | 443 | 0.120 |
Why?
|
| Play and Playthings | 1 | 2014 | 79 | 0.120 |
Why?
|
| Placenta | 1 | 2023 | 1698 | 0.120 |
Why?
|
| Administrative Personnel | 1 | 2015 | 187 | 0.120 |
Why?
|
| Metabolome | 2 | 2018 | 895 | 0.120 |
Why?
|
| Poisoning | 1 | 2015 | 249 | 0.120 |
Why?
|
| Affective Symptoms | 1 | 2017 | 407 | 0.120 |
Why?
|
| Rural Population | 3 | 2018 | 2210 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2017 | 3966 | 0.120 |
Why?
|
| Neuropsychological Tests | 4 | 2023 | 6993 | 0.120 |
Why?
|
| Faculty | 1 | 2017 | 386 | 0.110 |
Why?
|
| Idaho | 1 | 2013 | 16 | 0.110 |
Why?
|
| Paper | 1 | 2013 | 85 | 0.110 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 2203 | 0.110 |
Why?
|
| Phenotype | 6 | 2024 | 16365 | 0.110 |
Why?
|
| Respiratory Tract Infections | 2 | 2018 | 961 | 0.110 |
Why?
|
| Obstetric Labor, Premature | 2 | 2005 | 279 | 0.110 |
Why?
|
| Bangladesh | 3 | 2021 | 687 | 0.110 |
Why?
|
| Hospitals, Maternity | 1 | 2013 | 42 | 0.110 |
Why?
|
| Infant Care | 1 | 2014 | 183 | 0.110 |
Why?
|
| Utah | 1 | 2013 | 126 | 0.110 |
Why?
|
| Perception | 1 | 2019 | 1198 | 0.110 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 57 | 0.110 |
Why?
|
| Filtration | 1 | 2013 | 234 | 0.110 |
Why?
|
| Creatinine | 1 | 2018 | 1919 | 0.110 |
Why?
|
| Physicians | 3 | 2018 | 4567 | 0.110 |
Why?
|
| Hypothalamus | 1 | 1998 | 1063 | 0.110 |
Why?
|
| Urban Population | 3 | 2018 | 2021 | 0.100 |
Why?
|
| Fetal Macrosomia | 1 | 2013 | 124 | 0.100 |
Why?
|
| Intelligence Tests | 3 | 2019 | 505 | 0.100 |
Why?
|
| Medical Records | 2 | 2022 | 1413 | 0.100 |
Why?
|
| Research Design | 3 | 2020 | 5987 | 0.100 |
Why?
|
| Vitamins | 4 | 2024 | 1622 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 2 | 2014 | 1677 | 0.100 |
Why?
|
| Developing Countries | 1 | 2004 | 2815 | 0.100 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2018 | 816 | 0.100 |
Why?
|
| Lung | 3 | 2022 | 9856 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 104 | 0.100 |
Why?
|
| Societies, Medical | 2 | 2017 | 3743 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 722 | 0.100 |
Why?
|
| Insurance Claim Review | 1 | 2016 | 720 | 0.100 |
Why?
|
| Cervix Uteri | 1 | 2015 | 590 | 0.100 |
Why?
|
| Risk Reduction Behavior | 2 | 2023 | 1125 | 0.100 |
Why?
|
| Growth Charts | 1 | 2011 | 61 | 0.100 |
Why?
|
| Triiodothyronine | 2 | 2024 | 494 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 940 | 0.100 |
Why?
|
| Poverty | 3 | 2023 | 2660 | 0.100 |
Why?
|
| Psychological Tests | 1 | 2013 | 651 | 0.100 |
Why?
|
| Feeding Methods | 1 | 2011 | 35 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2019 | 785 | 0.100 |
Why?
|
| Qualitative Research | 3 | 2016 | 2682 | 0.100 |
Why?
|
| Weaning | 1 | 2011 | 105 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 906 | 0.090 |
Why?
|
| Exhalation | 2 | 2023 | 167 | 0.090 |
Why?
|
| Achievement | 1 | 2012 | 291 | 0.090 |
Why?
|
| Leukemia | 1 | 2019 | 1511 | 0.090 |
Why?
|
| Automobile Driving | 1 | 1995 | 431 | 0.090 |
Why?
|
| Trans Fatty Acids | 1 | 2011 | 153 | 0.090 |
Why?
|
| Aftercare | 1 | 2016 | 866 | 0.090 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 3229 | 0.090 |
Why?
|
| Air Pollution, Indoor | 1 | 2017 | 857 | 0.090 |
Why?
|
| Women | 1 | 1992 | 230 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2703 | 0.090 |
Why?
|
| Breath Tests | 2 | 2023 | 280 | 0.090 |
Why?
|
| Retrospective Studies | 7 | 2023 | 77449 | 0.090 |
Why?
|
| Antibodies | 1 | 1998 | 2460 | 0.090 |
Why?
|
| Communication | 2 | 2021 | 3749 | 0.090 |
Why?
|
| Probability | 4 | 2021 | 2505 | 0.090 |
Why?
|
| Methionine | 1 | 2012 | 590 | 0.090 |
Why?
|
| Glucose | 4 | 2022 | 4397 | 0.090 |
Why?
|
| Labor, Obstetric | 1 | 2013 | 333 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2453 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1799 | 0.090 |
Why?
|
| Visual Acuity | 1 | 2018 | 2530 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2018 | 4560 | 0.080 |
Why?
|
| Motor Skills | 1 | 2012 | 522 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2017 | 1401 | 0.080 |
Why?
|
| Exercise Therapy | 2 | 2017 | 906 | 0.080 |
Why?
|
| Thimerosal | 1 | 2008 | 16 | 0.080 |
Why?
|
| Aptitude Tests | 1 | 2008 | 21 | 0.080 |
Why?
|
| Area Under Curve | 3 | 2021 | 1654 | 0.080 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2008 | 31 | 0.080 |
Why?
|
| Nervous System | 1 | 2012 | 554 | 0.080 |
Why?
|
| DNA | 2 | 2020 | 7301 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2018 | 5078 | 0.080 |
Why?
|
| Dental Amalgam | 1 | 2008 | 67 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2019 | 21746 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2065 | 0.080 |
Why?
|
| Iron-Binding Proteins | 1 | 2008 | 79 | 0.080 |
Why?
|
| United States Environmental Protection Agency | 1 | 2008 | 139 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2133 | 0.070 |
Why?
|
| Iron, Dietary | 1 | 2008 | 141 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5867 | 0.070 |
Why?
|
| Perinatal Care | 1 | 2009 | 227 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 2838 | 0.070 |
Why?
|
| Intention to Treat Analysis | 2 | 2018 | 426 | 0.070 |
Why?
|
| Aging | 2 | 2024 | 8664 | 0.070 |
Why?
|
| Cattle | 2 | 2022 | 3922 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3674 | 0.070 |
Why?
|
| Leisure Activities | 1 | 2008 | 311 | 0.070 |
Why?
|
| Immune System | 1 | 2012 | 805 | 0.070 |
Why?
|
| Nails | 2 | 2019 | 292 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3870 | 0.070 |
Why?
|
| Behavior Therapy | 2 | 2022 | 865 | 0.070 |
Why?
|
| Fathers | 2 | 2023 | 358 | 0.070 |
Why?
|
| Telomere | 2 | 2022 | 910 | 0.070 |
Why?
|
| Vitamin A | 2 | 2017 | 615 | 0.070 |
Why?
|
| Genome, Human | 1 | 2019 | 4420 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3617 | 0.070 |
Why?
|
| Australia | 2 | 2019 | 1170 | 0.070 |
Why?
|
| Thyroid Hormones | 2 | 2024 | 390 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2012 | 2373 | 0.060 |
Why?
|
| Kidney | 1 | 2021 | 7186 | 0.060 |
Why?
|
| Honduras | 1 | 2004 | 36 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2018 | 3022 | 0.060 |
Why?
|
| Lymphocytes | 2 | 2019 | 2617 | 0.060 |
Why?
|
| Netherlands | 2 | 2021 | 2170 | 0.060 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2005 | 113 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 3336 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 1813 | 0.060 |
Why?
|
| Minority Groups | 1 | 1992 | 1223 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 2425 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4554 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15540 | 0.060 |
Why?
|
| Alkanesulfonates | 1 | 2023 | 15 | 0.060 |
Why?
|
| Food Preservation | 1 | 2003 | 14 | 0.060 |
Why?
|
| Respiratory Function Tests | 2 | 2020 | 1616 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2008 | 1534 | 0.060 |
Why?
|
| Health Surveys | 2 | 2011 | 4037 | 0.060 |
Why?
|
| Body Image | 1 | 2008 | 610 | 0.060 |
Why?
|
| Norway | 2 | 2017 | 448 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2017 | 3206 | 0.060 |
Why?
|
| Autoantigens | 1 | 2008 | 892 | 0.060 |
Why?
|
| Psychometrics | 2 | 2023 | 3002 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4420 | 0.060 |
Why?
|
| Particle Size | 2 | 2019 | 1642 | 0.060 |
Why?
|
| Prognosis | 4 | 2019 | 29063 | 0.060 |
Why?
|
| Electric Impedance | 2 | 2020 | 729 | 0.060 |
Why?
|
| Memory | 1 | 2013 | 2174 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1992 | 2232 | 0.050 |
Why?
|
| China | 2 | 2019 | 2248 | 0.050 |
Why?
|
| Dicarboxylic Acids | 1 | 2022 | 69 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2021 | 12208 | 0.050 |
Why?
|
| Body Constitution | 1 | 2003 | 278 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 200 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2014 | 2071 | 0.050 |
Why?
|
| Trees | 1 | 2022 | 58 | 0.050 |
Why?
|
| Forecasting | 1 | 2011 | 2951 | 0.050 |
Why?
|
| Thyroglobulin | 1 | 2022 | 114 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 1992 | 2057 | 0.050 |
Why?
|
| Motivation | 1 | 2012 | 1971 | 0.050 |
Why?
|
| Health Personnel | 1 | 2015 | 3218 | 0.050 |
Why?
|
| Vocabulary | 1 | 2022 | 169 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 169 | 0.050 |
Why?
|
| Cadmium | 1 | 2022 | 212 | 0.050 |
Why?
|
| Models, Structural | 1 | 2021 | 361 | 0.050 |
Why?
|
| Self Care | 1 | 2006 | 786 | 0.050 |
Why?
|
| Mediator Complex | 1 | 2021 | 109 | 0.050 |
Why?
|
| Rickets | 1 | 2001 | 74 | 0.050 |
Why?
|
| Guanine | 1 | 2022 | 274 | 0.050 |
Why?
|
| Cytosine | 1 | 2022 | 216 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 13881 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2021 | 344 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2008 | 1584 | 0.050 |
Why?
|
| Plethysmography | 1 | 2020 | 180 | 0.040 |
Why?
|
| Amenorrhea | 1 | 2023 | 485 | 0.040 |
Why?
|
| Reference Standards | 1 | 2003 | 1025 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3752 | 0.040 |
Why?
|
| Vaccines | 1 | 2008 | 822 | 0.040 |
Why?
|
| Oceania | 1 | 2018 | 17 | 0.040 |
Why?
|
| Trace Elements | 1 | 2020 | 198 | 0.040 |
Why?
|
| Creatine | 1 | 2001 | 421 | 0.040 |
Why?
|
| Superior Sagittal Sinus | 1 | 2018 | 17 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 643 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2022 | 553 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2022 | 2585 | 0.040 |
Why?
|
| Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
| ROC Curve | 2 | 2018 | 3527 | 0.040 |
Why?
|
| Phosphates | 1 | 2022 | 786 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2023 | 1000 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2003 | 1364 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2022 | 703 | 0.040 |
Why?
|
| Oklahoma | 1 | 2017 | 37 | 0.040 |
Why?
|
| Selection Bias | 1 | 2020 | 371 | 0.040 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2002 | 365 | 0.040 |
Why?
|
| Acinetobacter | 1 | 2017 | 39 | 0.040 |
Why?
|
| Decision Making | 1 | 1992 | 3887 | 0.040 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 275 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2023 | 687 | 0.040 |
Why?
|
| Plasma | 1 | 2021 | 575 | 0.040 |
Why?
|
| Plethysmography, Impedance | 1 | 2017 | 43 | 0.040 |
Why?
|
| Colorado | 1 | 2017 | 163 | 0.040 |
Why?
|
| Family | 2 | 2023 | 3147 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 2418 | 0.040 |
Why?
|
| Aryldialkylphosphatase | 1 | 2017 | 63 | 0.040 |
Why?
|
| Nitrogen Dioxide | 1 | 2019 | 490 | 0.040 |
Why?
|
| Interleukins | 1 | 2021 | 791 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2020 | 634 | 0.040 |
Why?
|
| North Carolina | 1 | 2017 | 315 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2022 | 1344 | 0.040 |
Why?
|
| Environmental Pollution | 1 | 2018 | 118 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2018 | 213 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 290 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 817 | 0.040 |
Why?
|
| Sex | 1 | 2016 | 57 | 0.030 |
Why?
|
| South Dakota | 1 | 1995 | 30 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 648 | 0.030 |
Why?
|
| Singapore | 1 | 2016 | 295 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 1205 | 0.030 |
Why?
|
| Fructose | 1 | 2018 | 288 | 0.030 |
Why?
|
| Seat Belts | 1 | 1995 | 57 | 0.030 |
Why?
|
| Social Class | 2 | 2019 | 1999 | 0.030 |
Why?
|
| Zimbabwe | 1 | 1995 | 129 | 0.030 |
Why?
|
| Social Responsibility | 1 | 2018 | 389 | 0.030 |
Why?
|
| Hexachlorobenzene | 1 | 2015 | 30 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1159 | 0.030 |
Why?
|
| Prehypertension | 1 | 2015 | 61 | 0.030 |
Why?
|
| Attitude to Health | 2 | 1997 | 2052 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2017 | 1095 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2016 | 305 | 0.030 |
Why?
|
| Aged | 5 | 2022 | 163280 | 0.030 |
Why?
|
| Organizations, Nonprofit | 1 | 2015 | 104 | 0.030 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2015 | 88 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
| International Agencies | 1 | 2015 | 240 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 2015 | 129 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2021 | 1236 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 976 | 0.030 |
Why?
|
| Developed Countries | 1 | 2017 | 437 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 764 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2043 | 0.030 |
Why?
|
| Medicaid | 2 | 2012 | 2736 | 0.030 |
Why?
|
| Temperature | 1 | 2020 | 2206 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 713 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 954 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3528 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2012 | 6365 | 0.030 |
Why?
|
| Intradermal Tests | 1 | 2013 | 44 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 440 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1941 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2015 | 245 | 0.030 |
Why?
|
| Hepatitis B | 1 | 2018 | 695 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1256 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
| Contraceptive Devices, Male | 1 | 1992 | 13 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 1465 | 0.030 |
Why?
|
| Taxes | 1 | 2014 | 221 | 0.030 |
Why?
|
| Housing | 1 | 2017 | 664 | 0.030 |
Why?
|
| Antigens | 1 | 1998 | 1466 | 0.030 |
Why?
|
| Fetal Weight | 1 | 2012 | 80 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2690 | 0.030 |
Why?
|
| Philadelphia | 1 | 2012 | 266 | 0.030 |
Why?
|
| Focus Groups | 1 | 2016 | 1321 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 2015 | 531 | 0.030 |
Why?
|
| Caregivers | 1 | 2023 | 2094 | 0.030 |
Why?
|
| New Jersey | 1 | 1992 | 290 | 0.020 |
Why?
|
| Ozone | 1 | 2015 | 469 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 15076 | 0.020 |
Why?
|
| Fetus | 1 | 2019 | 1880 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2020 | 1938 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 1836 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2020 | 2575 | 0.020 |
Why?
|
| Cultural Characteristics | 1 | 1992 | 262 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 3920 | 0.020 |
Why?
|
| Kinetics | 1 | 1998 | 6473 | 0.020 |
Why?
|
| Geographic Information Systems | 1 | 2012 | 281 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1519 | 0.020 |
Why?
|
| Gynecology | 1 | 2015 | 513 | 0.020 |
Why?
|
| Inservice Training | 1 | 2012 | 392 | 0.020 |
Why?
|
| Fasting | 1 | 2015 | 1593 | 0.020 |
Why?
|
| Biometry | 1 | 2012 | 558 | 0.020 |
Why?
|
| Education | 1 | 2012 | 543 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1708 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3520 | 0.020 |
Why?
|
| Telephone | 1 | 2012 | 617 | 0.020 |
Why?
|
| Gastroenterology | 1 | 2014 | 536 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2012 | 676 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5524 | 0.020 |
Why?
|
| Diet, Vegetarian | 1 | 2009 | 174 | 0.020 |
Why?
|
| Oral Health | 1 | 2013 | 472 | 0.020 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 290 | 0.020 |
Why?
|
| Erythrocyte Indices | 1 | 2008 | 146 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 12354 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 2593 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2889 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3508 | 0.020 |
Why?
|
| Gender Identity | 1 | 1992 | 688 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9146 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Systole | 1 | 2008 | 958 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2009 | 481 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 1049 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3589 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1170 | 0.020 |
Why?
|
| Cytokines | 1 | 2019 | 7322 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7880 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2759 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 747 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2014 | 63114 | 0.010 |
Why?
|
| Exercise Test | 1 | 2011 | 2074 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 15519 | 0.010 |
Why?
|
| Pain | 1 | 1998 | 4986 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2001 | 7659 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 17446 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 13033 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 7913 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2014 | 4558 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2001 | 517 | 0.010 |
Why?
|
| Iowa | 1 | 1997 | 101 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 12072 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8340 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2886 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14722 | 0.010 |
Why?
|
| Hospitalization | 1 | 2013 | 10262 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35421 | 0.010 |
Why?
|
| Age Distribution | 1 | 1998 | 2902 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10481 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2001 | 1901 | 0.010 |
Why?
|